Similar articles

• [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].

  [No authors listed] [No authors listed] Kekkaku. 1971 Oct;46(10):393-9. Kekkaku. 1971. PMID: 5147895 Japanese. No abstract available.
• [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].

  Weill G, Lévy A, Guignon JP, Lecoq H, Friess JM, Maman P. Weill G, et al. Rev Tuberc Pneumol (Paris). 1969 Dec;33(8):1119-25. Rev Tuberc Pneumol (Paris). 1969. PMID: 4916253 Clinical Trial. French. No abstract available.
• [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].

  Szymański A. Szymański A. Pneumonol Pol. 1976 Mar;44(3):227-35. Pneumonol Pol. 1976. PMID: 1257096 Polish. No abstract available.
• [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].

  Engbaek HC, Larsen SO, Rasmussen KN, Vergmann B. Engbaek HC, et al. Ugeskr Laeger. 1973 Aug 20;135(34):1795-9. Ugeskr Laeger. 1973. PMID: 4592618 Review. Danish. No abstract available.
• Genetic factors in drug therapy.

  Evans DA. Evans DA. Sci Basis Med Annu Rev. 1969:166-82. Sci Basis Med Annu Rev. 1969. PMID: 4918368 Review. No abstract available.